What is LOPJLB’s current signal on KAPA?

LOPJLB’s latest quantitative signal on Kairos Pharma, Ltd. (KAPA) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is KAPA in?

Kairos Pharma, Ltd. (KAPA) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Kairos Pharma, Ltd. (KAPA) do?

Kairos Pharma, Ltd. operates as a clinical-stage biopharmaceutical company focused on developing innovative treatments for individuals battling cancer. Its therapeutic portfolio includes a range of antibodies and small molecules engineered to combat various malignancies, such as prostate, lung, and breast cancer, as well as glioblastoma. Initially incorporated in 2013 under the name NanoGB13, I…

Where is Kairos Pharma, Ltd. based / listed?

Kairos Pharma, Ltd. is based in US, listed on AMEX.

Kairos Pharma, Ltd. (KAPA)

COMPARE

Healthcare · Biotechnology · AMEX · US

$0.81-15.62%Close

SELLCRISIS · day 41

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $17M
Beta: 1.45
P/E (TTM): -0.59

Short % float: 1.26%
Days to cover: 1.0
SI change: -1.1%

1W: -48.08%
1M: -51.79%

vs SPY 1W: -49.24%
vs SPY 1M: -54.78%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Prediction markets

Company news